Tags

Type your tag names separated by a space and hit enter

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Nov 06; 69(44):1635-1640.MM

Abstract

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (<37 weeks), higher than the reported 10.2% among the general U.S. population in 2019 (4). Among 610 infants (21.3%) with reported SARS-CoV-2 test results, perinatal infection was infrequent (2.6%) and occurred primarily among infants whose mother had SARS-CoV-2 infection identified within 1 week of delivery. Because the majority of pregnant women with COVID-19 reported thus far experienced infection in the third trimester, ongoing surveillance is needed to assess effects of infections in early pregnancy, as well the longer-term outcomes of exposed infants. These findings can inform neonatal testing recommendations, clinical practice, and public health action and can be used by health care providers to counsel pregnant women on the risks of SARS-CoV-2 infection, including preterm births. Pregnant women and their household members should follow recommended infection prevention measures, including wearing a mask, social distancing, and frequent handwashing when going out or interacting with others or if there is a person within the household who has had exposure to COVID-19.†.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33151917

Citation

Woodworth, Kate R., et al. "Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020." MMWR. Morbidity and Mortality Weekly Report, vol. 69, no. 44, 2020, pp. 1635-1640.
Woodworth KR, Olsen EO, Neelam V, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635-1640.
Woodworth, K. R., Olsen, E. O., Neelam, V., Lewis, E. L., Galang, R. R., Oduyebo, T., Aveni, K., Yazdy, M. M., Harvey, E., Longcore, N. D., Barton, J., Fussman, C., Siebman, S., Lush, M., Patrick, P. H., Halai, U. A., Valencia-Prado, M., Orkis, L., Sowunmi, S., ... Tong, V. T. (2020). Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(44), 1635-1640. https://doi.org/10.15585/mmwr.mm6944e2
Woodworth KR, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635-1640. PubMed PMID: 33151917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. AU - Woodworth,Kate R, AU - Olsen,Emily O'Malley, AU - Neelam,Varsha, AU - Lewis,Elizabeth L, AU - Galang,Romeo R, AU - Oduyebo,Titilope, AU - Aveni,Kathryn, AU - Yazdy,Mahsa M, AU - Harvey,Elizabeth, AU - Longcore,Nicole D, AU - Barton,Jerusha, AU - Fussman,Chris, AU - Siebman,Samantha, AU - Lush,Mamie, AU - Patrick,Paul H, AU - Halai,Umme-Aiman, AU - Valencia-Prado,Miguel, AU - Orkis,Lauren, AU - Sowunmi,Similoluwa, AU - Schlosser,Levi, AU - Khuwaja,Salma, AU - Read,Jennifer S, AU - Hall,Aron J, AU - Meaney-Delman,Dana, AU - Ellington,Sascha R, AU - Gilboa,Suzanne M, AU - Tong,Van T, AU - ,, AU - ,, Y1 - 2020/11/06/ PY - 2020/11/5/entrez PY - 2020/11/6/pubmed PY - 2020/11/11/medline SP - 1635 EP - 1640 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 69 IS - 44 N2 - Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (<37 weeks), higher than the reported 10.2% among the general U.S. population in 2019 (4). Among 610 infants (21.3%) with reported SARS-CoV-2 test results, perinatal infection was infrequent (2.6%) and occurred primarily among infants whose mother had SARS-CoV-2 infection identified within 1 week of delivery. Because the majority of pregnant women with COVID-19 reported thus far experienced infection in the third trimester, ongoing surveillance is needed to assess effects of infections in early pregnancy, as well the longer-term outcomes of exposed infants. These findings can inform neonatal testing recommendations, clinical practice, and public health action and can be used by health care providers to counsel pregnant women on the risks of SARS-CoV-2 infection, including preterm births. Pregnant women and their household members should follow recommended infection prevention measures, including wearing a mask, social distancing, and frequent handwashing when going out or interacting with others or if there is a person within the household who has had exposure to COVID-19.†. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/33151917/Birth_and_Infant_Outcomes_Following_Laboratory_Confirmed_SARS_CoV_2_Infection_in_Pregnancy___SET_NET_16_Jurisdictions_March_29_October_14_2020_ L2 - https://doi.org/10.15585/mmwr.mm6944e2 DB - PRIME DP - Unbound Medicine ER -